Retrospective analysis of risks and benefits of trimethoprim/sulfamethoxazole as prophylaxis for Pneumocystis jiroveci pneumonia in patients with dermatologic disease. Academic Article uri icon

Overview

publication date

  • February 15, 2023

Research

keywords

  • Pneumocystis carinii
  • Pneumonia, Pneumocystis

Identity

Scopus Document Identifier

  • 85150060380

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2023.01.041

PubMed ID

  • 36796726

Additional Document Info

volume

  • 88

issue

  • 6